Adam Mendelsohn - Vivani Medical Chairman CoFounder
| VANI Stock | USD 1.20 0.01 0.83% |
Insider
Adam Mendelsohn is Chairman CoFounder of Vivani Medical
| Age | 43 |
| Address | 1350 South Loop Road, Alameda, CA, United States, 94502 |
| Phone | 415 506 8462 |
| Web | https://www.vivani.com |
Vivani Medical Management Efficiency
The company has return on total asset (ROA) of (0.2929) % which means that it has lost $0.2929 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.861) %, meaning that it created substantial loss on money invested by shareholders. Vivani Medical's management efficiency ratios could be used to measure how well Vivani Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.53. The current Return On Capital Employed is estimated to decrease to -0.81. As of now, Vivani Medical's Other Current Assets are increasing as compared to previous years. The Vivani Medical's current Net Tangible Assets is estimated to increase to about 82.6 M, while Total Current Assets are projected to decrease to under 19.6 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Niels Svenstrup | PepGen | 55 | |
| Jochen Knolle | Pharvaris BV | 74 | |
| Wim Souverijns | Pharvaris BV | 54 | |
| Eric Easom | AN2 Therapeutics | 57 | |
| Robert Hudkins | Tyra Biosciences | 69 | |
| Annick Deschoolmeester | Pharvaris BV | 52 | |
| Hiroomi MD | Tyra Biosciences | 60 | |
| Thomas Shenk | Pmv Pharmaceuticals | 77 | |
| MD FACP | AN2 Therapeutics | 77 | |
| Michael Gait | PepGen | N/A | |
| Ronald Swanson | Tyra Biosciences | 61 | |
| Kenneth Cundy | Anebulo Pharmaceuticals | 66 | |
| Morgan Conn | Pharvaris BV | 55 | |
| Amy Conrad | Tyra Biosciences | N/A | |
| Caroline Godfrey | PepGen | N/A | |
| David Mack | Pmv Pharmaceuticals | 63 | |
| Josh Eizen | AN2 Therapeutics | N/A | |
| Noel MBA | PepGen | 55 | |
| Deepika PharmD | Pmv Pharmaceuticals | 49 | |
| Jeffrey CPA | Rallybio Corp | 54 | |
| Jennifer Cormier | PepGen | N/A | |
Management Performance
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.29 |
Vivani Medical Leadership Team
Elected by the shareholders, the Vivani Medical's board of directors comprises two types of representatives: Vivani Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vivani. The board's role is to monitor Vivani Medical's management team and ensure that shareholders' interests are well served. Vivani Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vivani Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brigid Makes, Chief Officer | ||
| Adam Mendelsohn, Chairman CoFounder | ||
| Truc MBA, Chief Officer | ||
| Donald MBA, Chief Secretary | ||
| Lisa MD, Chief Officer | ||
| Kayte Fischer, CoFounder |
Vivani Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vivani Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | 71.71 M | ||||
| Shares Outstanding | 59.23 M | ||||
| Shares Owned By Insiders | 52.50 % | ||||
| Shares Owned By Institutions | 10.46 % | ||||
| Number Of Shares Shorted | 357.99 K | ||||
| Price To Book | 3.91 X | ||||
| Gross Profit | 130 K | ||||
| EBITDA | (26.61 M) |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivani Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vivani Medical is measured differently than its book value, which is the value of Vivani that is recorded on the company's balance sheet. Investors also form their own opinion of Vivani Medical's value that differs from its market value or its book value, called intrinsic value, which is Vivani Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivani Medical's market value can be influenced by many factors that don't directly affect Vivani Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivani Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.